Definition of discontinuation of anti-tumour necrosis factor therapy in rheumatoid arthritis: a preliminary proposal

Documenti analoghi

• International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
  di: Braun, J, et al.
  Pubblicazione: (2003)
• Neutropenia while receiving anti‐tumour necrosis factor treatment for rheumatoid arthritis
  di: Rajakulendran, S, et al.
  Pubblicazione: (2006)
• Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
  di: Leandro, Maria J
  Pubblicazione: (2009)
• Peptostreptococcal pericarditis complicating anti-tumour necrosis factor α treatment in rheumatoid arthritis
  di: Harney, S, et al.
  Pubblicazione: (2002)
• Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents
  di: Russell, A, et al.
  Pubblicazione: (2005)